LFCR
Lifecore Biomedical Inc.
6.50$
+55.2%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | -1.6% | -1.5% | +6.4% | -71.3% | -37.0% | +84.2% | -40.1% | +15.3% | +0.5% | +0.5% | |
| – | -0.8% | -4.5% | -0.7% | +6.9% | -74.7% | -48.7% | +118.6% | -46.7% | +19.7% | +2.5% | +0.3% | |
| – | +8.5% | +17.2% | -5.8% | +3.4% | -51.4% | -1.1% | +29.4% | -22.4% | +7.1% | -3.7% | +0.8% | |
| – | +3.4% | +31.1% | +35.1% | -10.4% | -33.9% | -11.8% | +17.3% | 0.0% | +9.4% | -3.7% | +3.0% | |
| – | – | +18.8% | -10.2% | +24.2% | +14.9% | -9.5% | -29.3% | -8.0% | +1.4% | +2.4% | – | |
| – | +20.9% | +19.3% | -4.3% | +16.6% | -13.6% | -26.8% | +13.0% | -5.8% | -0.3% | +13.5% | -27.2% | |
| – | -207.2% | – | -23.6% | -167.6% | – | – | – | – | – | – | – | |
| – | +8.6% | -8.1% | +6.8% | +168.2% | -11.2% | +92.3% | +94.3% | -10.4% | +16.3% | +20.7% | -89.9% | |
| – | -187.8% | – | +9.2% | -77.8% | -941.9% | – | – | – | – | -506.5% | – | |
| – | -195.6% | – | -316.0% | – | -678.0% | – | – | – | – | -76.5% | +1,243.5% | |
| – | -185.9% | – | +134.5% | -91.5% | -1,899.8% | – | – | – | – | -422.3% | – | |
| – | -125.7% | – | -6.3% | -6.1% | -130.5% | – | – | – | +177.2% | -124.8% | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.